Peregrine Asset Advisers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,456
Closed -$314K 94
2022
Q1
$314K Hold
2,456
0.16% 81
2021
Q4
$330K Buy
+2,456
New +$353K 0.13% 93
2020
Q3
Sell
-23,320
Closed -$2.36M 101
2020
Q2
$2.36M Buy
+23,320
New +$2.09M 1.34% 26

Other funds holding DXCM

Peregrine Asset Advisers's DXCM Position: Q2 2022 in Review

Peregrine Asset Advisers sold out of DexCom (DXCM) in Q2 2022, closing a stake of 2,456 shares — an estimated $314K sold.

Peregrine Asset Advisers first reported a position in DXCM in Q2 2020 and held it in 3 quarters. The position peaked at $2.36M in Q2 2020. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Peregrine Asset Advisers reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Peregrine Asset Advisers sold 2,456 DexCom shares in Q2 2022, an estimated $314K.
  • Peregrine Asset Advisers first reported a position in DexCom in Q2 2020 and held it in 3 quarters.
  • Peregrine Asset Advisers's DexCom position peaked at $2.36M in Q2 2020.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Peregrine Asset Advisers's 13F filing for Q2 2022, filed 9 Aug 2022.